BPCA and PREA Reauthorization
The House Childhood Cancer Caucus supports bipartisan efforts to reauthorize and strengthen the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA).
WASHINGTON, D.C. – Today, U.S. Representatives Michael T. McCaul (R-TX-10) and G. K. Butterfield (D-NC-01) released the following statements after their bipartisan bill, H.R. 1231, RACE for Children Act (Research to Accelerate Cures and Equity for Children Act), passed the House with overwhelming support.
The House Childhood Cancer Caucus hosted its Second Annual Childhood Cancer Summit on September 23, 2011 on Capitol Hill. The Summit featured a panel discussion entitled "The Future of Childhood Cancer Drug Development", which addressed the current state of drug development, access to clinical trials and the changes which could spur progress in these fields. Actor Dennis Quaid also delivered a message during this year's Summit.